机构地区:[1]新疆维吾尔自治区疾病预防控制中心,新疆维吾尔自治区乌鲁木齐830011 [2]新疆医科大学公共卫生学院
出 处:《中国预防医学杂志》2025年第2期206-210,共5页Chinese Preventive Medicine
基 金:中华预防医学会疫苗与免疫青年人才托举项目(CPMAQT_YM0345)。
摘 要:目的分析新疆维吾尔自治区(新疆)适龄儿童非免疫规划(non-National Immunization Program,nNIP)疫苗接种情况,为nNIP疫苗的管理提供参考依据。方法收集并整理新疆“免疫规划信息管理系统”中2021—2023年适龄儿童的nNIP疫苗接种数据,对各剂次nNIP疫苗进行描述性分析。结果2021—2023年新疆“免疫规划信息管理系统”中有效管理的适龄儿童473万人,接种nNIP疫苗188.45万剂次。流感、水痘、肠道病毒71型、乙肝、13价肺炎疫苗、狂犬、百白破-脊灰灭活疫苗-b型流感嗜血杆菌(五联)、轮状病毒、b型流感嗜血杆菌、23价肺炎疫苗、百白破型流感嗜血杆菌(四联)、甲肝灭活、ACYW135群脑膜炎球菌多糖疫苗使用量较多,人均接种剂次在1.37剂次/万人~1550.98剂次/万人。2021—2023年新疆nNIP疫苗中,按疫苗分,流感疫苗接种剂次数最高为566653剂次,其次为水痘减毒活疫苗,再次为肠道病毒71型灭活疫苗;按年龄分,2021—2023年均以1~<2岁组人均接种剂次数最高,2021年为5787.31剂次/万人,2022年为5150.00剂次/万人和2023年为6945.27剂次/万人。0~<1岁组人均接种剂次数最低,2021年为3165.95剂次/万人,2022年为1892.69剂次/万人和2023年为2894.74剂次/万人。2023年新疆nNIP疫苗人均接种剂次增幅较2021年比,增幅较大的是4~<5岁组129900剂次(49.82%),5~<6岁组112609剂次(39.02%),增幅较小的是2~<3岁组75009剂次(5.35%);按地区分,2021—2023年均以克拉玛依市人均接种剂次数最高,2021年为9179.61剂次/万人,2022年为6602.11剂次/万人和2023年为11738.80剂次/万人。喀什地区人均接种剂次数最低,2021年为1039.21剂次/万人,2022年为632.00剂次/万人和2023年为1070.40剂次/万人。2021—2023年,人均接种剂次增幅较大的地(州、市)是哈密地区(136.18%),2021年为4281.73剂次/万人,2023年为10112.57剂次/万人;巴音郭楞蒙古自治州(72.72%),2021年为3431.32剂次/万人,2023年为5926.74剂�Objective To analyze the vaccination coverage of Non-National Immunization Program Vaccine(nNIP)among age-eligible children in Xinjiang Uygur Autonomous Region(Xinjiang),and to provide a reference for the management of nNIP vaccine.Methods The nNIP vaccination data of age-eligible children in Xinjiang Immunization Program Information Management System(Xinjiang IPIMS)for 2021—2023 were collected and collated,and descriptive analyses were conducted on the vaccination doses administered.Results From 2021 to 2023,a total of 4.73 million age-eligible children were effectively managed in the Xinjiang immunization system,receiving 18845 million doses of nNIP vaccines.The most frequently administered nNIP vaccines included influenza,varicella,enterovirus 71,hepatitis B,13-valent pneumonia conjugate vaccine,rabies,DTPa-HibIPV(pentavalent),rotavirus,Haemophilus influenzae type b,23-valent pneumococcal polysaccharide vaccine,DTPa-Hib(quadrivalent),inactivated hepatitis A,and ACYW135 meningococcal polysaccharide Vaccine.The per capita vaccination rates ranged from 1.37 doses per million individuals to 1550.98 doses per million people.Among nNIP vaccines,the highest number of doses administered was for the influenza vaccine(566653 doses),followed by the live attenuated varicella vaccine and the inactivated enterovirus 71 vaccine.By age group,children aged 1 to<2 years had the highest per capita vaccination rates,with 5787.31 doses per 10000 in 2021,5150.00 in 2022,and 6945.27 in 2023.The lowest rates were observed in the 0 to<1 year group.Notably,the increase in per capita vaccination doses in 2023 compared to 2021 was most significant in the 4 to<5 years age group(129900 doses,49.82%)and the 5 to<6 years group(112609 doses,39.02%).Regionally,Karamay City consistently had the highest per capita vaccination rates,while Kashgar had the lowest.From 2021 to 2023,the regions with the most significant increases in per capita doses were Hami(136.18%)and Bayinguoleng Mongol Autonomous Prefecture(72.72%).Conclusions To enhance nNIP
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...